Now Available! Updated NCCN Guidelines for Patients®: Melanoma
Lacey Marlow, Associate Medical Writer
The NCCN Guidelines for Patients®: Melanoma, Version 1.2013, is now available on NCCN.org and NCCN.com.
The NCCN Guidelines for Patients®: Melanoma has been updated to reflect the content of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Melanoma, Version 2.2013. This NCCN Guidelines for Patients® is a high-quality resource for patients and caregivers in the process of planning or receiving treatment. It includes NCCN's most recent treatment recommendations for each stage of melanoma skin cancer.
This update includes important changes to the recommended systemic therapy options for advanced or metastatic melanoma. These options are now divided into "preferred" and "other" regimens. Also, imatinib mesylate (Gleevec®) for melanomas with c-kit mutations has been added to the "other regimens" category.
The NCCN Guidelines for Patients®: Melanoma was developed according to plain language principles to improve health literacy. The booklet has been redesigned into a patient-friendly format and includes descriptions of recommended tests and treatments, as well as definitions of medical terms. This resource also includes medical illustrations of anatomy, tests, and treatments that may help patients to better understand the cancer and treatment process. The NCCN Guidelines for Patients®: Melanoma is available free-of-charge at NCCN.com and NCCN.org.
NCCN currently offers 12 NCCN Guidelines for Patients® for the following: breast, colon, ovarian, melanoma, non-small cell lung, pancreatic, and prostate cancers, chronic myelogenous leukemia, lung cancer screening, malignant pleural mesothelioma, multiple myeloma, and caring for adolescents and young adults (AYA).